| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGAAAGCCGCGCACCUCCUCCCGCCAGGCGCUUUCUCGGACGCCUUGCC… | 2174 nt | 0.3680 | |
| AGAAAGCCGCGCACCUCCUCCCGCCAGGCGCUUUCUCGGACGCCUUGCC… | 2131 nt | 0.3693 | |
| AGAAAGCCGCGCACCUCCUCCCGCCAGGCGCUUUCUCGGACGCCUUGCC… | 2207 nt | 0.3706 |
This gene encodes a member of the Kunitz-type serine proteinase inhibitor family. The protein can inhibit a variety of serine proteases including factor VIIa/tissue factor, factor Xa, plasmin, trypsin, chymotryspin and plasma kallikrein. This gene has been identified as a tumor suppressor gene in several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
A study in human and rat skin demonstrated that ultraviolet-B (UVB)-induced inflammation at the peak of hyperalgesia significantly up-regulated the TFPI2 in both species, with a fold change of 15.5 in human skin and 29.2 in rat skin, as part of a large transcriptional response involving numerous cytokines, chemokines, and other mediators [Dawes et al. DOI:10.1371/journal.pone.0093338]. A study in burn-injured rats and human keratinocytes demonstrated that overexpression of the m6A eraser FTO inhibits the TFPI2 mRNA, promoting the proliferation and migration of heat-stimulated keratinocytes and accelerating burn wound healing [Zhang et al. DOI:10.7150/ijbs.114988].